Patient Safety and Risk Management

PS-053

SEVERE THROMBOCYTOPENIA INDUCED BY REGORAFENIB IN A METASTATIC COLON CANCER PATIENT: A CASE REPORT

PS-050

THE IMPLEMENTATION OF A RETROACTIVE MEDICATION RECONCILIATION PROCESS AT ADMISSION REDUCES THE RATE OF PRESCRIPTION ERRORS IN AN ACUTE CARDIOLOGY UNIT

PS-048

A BAR CODE ASSISTED CHEMOTHERAPY ADMINISTRATION SYSTEM IN CANCER PATIENTS

PS-047

RESULTS OF AN ALLERGY DETECTION PROGRAMME OVER PREOPERATIVE ANTIBIOTIC PROPHYLAXIS

PS-045

LOOK-ALIKE INJECTABLE DRUGS: DETECTION AND FIRST ASSESSMENT

PS-044

FOOD AND DRUG INTERACTIONS IN ORAL CANCER THERAPY

PS-043

MEDICATION RECONCILIATION AT HOSPITAL ADMISSION: RESULTS EVALUATION AND FUTURE PROSPECTS

PS-042

POTENTIAL INTERACTIONS IN PATIENTS TREATED WITH DABIGATRAN, PREVALENCE AND THERAPEUTIC APPROACH

PS-041

DRUG DOSING ADJUSTMENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE ADMITTED TO HOSPITAL THROUGH THE EMERGENCY DEPARTMENT

PS-040

DRUG DOSAGE ERRORS IN THE TREATMENT OF ALZHEIMER’S DISEASE

PS-038

SAFE ADMINISTRATION OF MEDICATION THROUGH ENTERAL FEEDING IN HOSPITALISED PATIENTS

PS-036

IMPROVING PHARMACOLOGICAL TREATMENT: REAL TIME SAFETY AUDITS

PS-035

COMPLEMENTARY MEDICINE USAGE IN CANCER PATIENTS

PS-034

PHARMACIST INTERVENTIONS TO REDUCE RISK FACTORS IN FALLS RELATED TO THE SEDATIVE EFFECTS OF DRUGS IN ELDERLY PATIENTS

PS-031

ON THE CLINICAL EVIDENCE LEADING TO TETRAZEPAM WITHDRAWAL

Pages